Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
M701（一种抗EpCAM × 抗CD3双特异性抗体）的研发和临床试验：一种针对晚期实体瘤引起的恶性腹水的靶向腹腔内疗法
期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00727-3
Liu, Rongrui; Lin, Rongbo; Li, Ning; Li, Guiling; Zhang, Tao; Zhao, Jun; Li, Jiayi; Sun, Meili; Wang, Ke; An, Hanxiang; Zhang, Weijie; Xu, Huiting; Zeng, Shan; Zhang, Mingjun; Duan, Wei; Bai, Yuxian; Zhang, Jingdong; Tian, He; Yin, Fei; Kang, Yu; Xu, Qi; Xu, Nong; Deng, Yanhong; Chen, Qing; Li, Yongqiang; Yang, Hongying; Su, Fang; Xiao, Zhenghong; Xiang, Xiaojun; Zhou, Pengfei; Huang, Shaoyi; Zhang, Jing; Xu, Jianming
